Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChill Brands Regulatory News (CHLL)

Share Price Information for Chill Brands (CHLL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.05
Bid: 2.00
Ask: 2.10
Change: -0.15 (-6.98%)
Spread: 0.10 (5.00%)
Open: 2.15
High: 2.00
Low: 2.00
Prev. Close: 2.15
CHLL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Dispensary Sales Pilot Programme

12 Oct 2022 08:00

RNS Number : 6172C
Chill Brands Group PLC
12 October 2022
 

12 October 2022

Chill Brands Group plc

("Chill Brands" or the "Company")

 

Launch of Dispensary Sales Pilot Programme

Chill Brands Group, the international consumer packaged goods company, is pleased to announce the launch of its CBD products into select cannabis dispensaries as part of a new sales pilot programme.

The pilot scheme will see Chill Brands' products enter an initial 20 fully licensed dispensaries as the Company gathers sales data and customer insights. Additional locations will be onboarded during Q4 2022. Following the completion of this pilot phase, the Company intends to scale its dispensary sales to additional locations across the United States.

During 2021, dispensaries in Colorado alone generated in excess of US $2 billion from sales of cannabis-based products. Consumers that frequent these stores typically have higher levels of discretionary income than convenience store shoppers, are already aware of and interested in cannabinoids including CBD, and are open to trialing new brands and products. They are supported by expert sales personnel known as 'budtenders', who act as cannabis sommeliers to guide consumers towards suitable products.

The programme will be launched in conjunction with Bellator and Dyspense, both Colorado-based sales and retail logistics companies with specific expertise in cannabis products.

Further updates will be provided as the pilot scheme progresses.

Timothy Ruybal Jr., Founder of Dyspense Technologies, commented:

"Dyspense looks forward to the launch of the Chill brand into Colorado dispensaries, where we have seen a steep increase in CBD only product sales over the last 24 month. Chill products provide a unique alternative for tobacco and THC consumers and we look forward to working with the Company to expand its footprint."

Callum Sommerton, Chief Executive Officer of Chill Brands, commented:

"We are excited to be expanding our US retail distribution footprint once more. This pilot programme is an opportunity to diversify the sales venues in which Chill products can be found. As demand for novel, non-psychoactive products continues to grow, we will be well positioned to offer Chill CBD to target consumers both to complement their cannabis purchases and as a non-intoxicating recreational alternative to THC.

We are grateful to our partners at Bellator and Dyspense for their support, and look forward to working with these industry experts as we seek to scale our operations within the dispensary environment."

-ENDS-

About Chill Brands Group

Chill Brands Group plc (LSE: CHLL, OTCQB: CHBRF) is an international company concerned with the development, production, and distribution of best-in-class hemp-derived CBD products, tobacco alternatives and other consumer packaged goods (CPG) products. The Company operates primarily in the US, where its products are distributed online and via some of the nation's most recognisable convenience retail outlets. The Group's strategy is anchored around lifestyle marketing that is designed to enhance the popularity of its products, channelling visitors to its landmark chill.com website.

Publication on website

A copy of this announcement is also available on the Group's website at http://www.chillbrandsgroup.com

Media enquiries:

Chill Brands Group plc

contact@chillbrandsgroup.com

Allenby Capital Limited (Financial Adviser and Broker)

+44 (0) 20 3328 5656

Nick Harriss/Nick Naylor (Corporate Finance)

Kelly Gardiner (Equity Sales)

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABKBBBABDKQKD
Date   Source Headline
22nd Apr 20247:00 amRNSSuspension of CEO
17th Apr 20243:18 pmRNSReceipt of Requisition Letter
16th Apr 20247:00 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSInvestor Presentation via Investor Meet Company
31st Jan 20245:00 pmRNSTotal Voting Rights
29th Jan 20247:00 amRNSResponse to Government Proposals
26th Jan 20247:00 amRNSEquity Fundraising
3rd Jan 20247:00 amRNSProduct Strategy Update
29th Dec 202312:30 pmRNSTotal Voting Rights
28th Dec 20237:00 amRNSHalf-year Report for the 6 months to 30 Sep 2023
22nd Dec 20237:00 amRNSProduct Sale to Leading Forecourt Operator
20th Dec 20237:00 amRNSVape Sale into Major Retailer
7th Dec 20237:00 amRNSTrading Statement
30th Nov 20231:15 pmRNSPublication of a Prospectus
17th Nov 20237:00 amRNSSale of Vapes to Leading UK Distributor
9th Nov 20237:00 amRNSProducts to Launch on Leading UK Wholesale Website
12th Oct 20237:00 amRNSProduct Launch on Amazon
9th Oct 20237:00 amRNSVape Sale to Major Retailer
19th Sep 20236:00 pmRNSResult of AGM
19th Sep 20237:00 amRNSAGM Statement
11th Sep 20237:00 amRNSProvisional Grant of Share Options
7th Sep 20237:00 amRNSTrading Update
24th Aug 20237:00 amRNSNotice of AGM
28th Jul 20231:00 pmRNSFinal Results for the year to 31 March 2023
21st Jun 20237:00 amRNSUpdate on Chill.com Marketplace
5th Jun 20237:00 amRNSUpdate on Shipping of Vapour Products
31st May 20235:00 pmRNSTotal Voting Rights
18th May 20237:30 amRNSUK Sales and Distribution Partnership
15th May 20235:45 pmRNSHolding(s) in Company
15th May 202311:30 amRNSHolding(s) in Company
15th May 20237:00 amRNSIssue of Equity
3rd Apr 20237:00 amRNSCompany Raises £2.6 million
31st Mar 20235:00 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSLaunch of Vapour Products
16th Mar 20232:45 pmRNSCompany Raises £560,000
14th Mar 20239:30 amRNSHolding(s) in Company
16th Feb 20237:00 amRNSCommencement of Third-Party Sales
28th Dec 202212:00 pmRNSHalf-year Report for the period to 30 Sept. 2022
12th Dec 20227:00 amRNSExpansion of Retail Programme
7th Dec 20227:00 amRNSPlanned Launch of Vape Products
31st Oct 20225:04 pmRNSResult of Adjourned AGM
31st Oct 20227:00 amRNSTrading Statement ahead of AGM
19th Oct 202211:53 amEQSChill Brands kicks off 'new era' with website relaunch
18th Oct 20227:00 amRNSConsumer Website Launch
12th Oct 20228:00 amRNSLaunch of Dispensary Sales Pilot Programme
30th Sep 20227:45 amRNSFinal Results for the year to 31 March 2022
29th Sep 20224:30 pmRNSResult of AGM
29th Sep 20221:00 pmRNSAGM Statement
23rd Sep 20228:00 amRNSUK Marketing Partnership
13th Sep 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.